Literature DB >> 16416990

[Ophthalmological tests value in detection of the optic neuropathy associated with pituitary tumours].

Anna Piekarska1, Wojciech Lubiński, Olgierd Palacz, Wiesława Wieliczko, Sławomir Pynka, Zbigniew Szych, Danuta Karczewicz.   

Abstract

PURPOSE: To evaluate the value of ophthalmological tests in detection of the optic neuropathy associated with pituitary tumours.
MATERIAL AND METHODS: 38 patients with pituitary tumours in 21-73 years old, were examined. Routine ophthalmological examination, kinetic and static perimetry (screening test, "white-on-white" and "blue-on-yellow") and PVEP were performed.
RESULTS: In patients with recurrent tumours (group II) more changes was observed in routine ophthalmological examination, perimetry and PVEP compared to patients with early detected pituitary tumours (group I). No patient of group I present changes in routine ophthalmological examination, but they had visual field defects and/or abnormal PVEP. In group I in Ps B-Y more visual field defects was detected than in kinetic perimetry (p<0.025). In the same group hemifield PVEP was more often abnormal than full-field PVEP (p<0.01). In group II similar differences were not observed.
CONCLUSIONS: In patients with pituitary tumours the most useful test in the optic neuropathy diagnosis are "blue-on-yellow" static perimetry and hemifield PVEP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16416990

Source DB:  PubMed          Journal:  Klin Oczna        ISSN: 0023-2157


  3 in total

1.  The clinical value of the multi-channel PVEP and PERG in the diagnosis and management of the patient with pituitary adenoma: a case report.

Authors:  Ewelina Lachowicz; Wojciech Lubiński
Journal:  Doc Ophthalmol       Date:  2018-07-02       Impact factor: 2.379

Review 2.  The importance of the electrophysiological tests in the early diagnosis of ganglion cells and/or optic nerve dysfunction coexisting with pituitary adenoma: an overview.

Authors:  Ewelina Lachowicz; Wojciech Lubiński
Journal:  Doc Ophthalmol       Date:  2018-10-29       Impact factor: 2.379

3.  The electrophysiological tests in the early detection of the visual pathway dysfunction in patients with microadenoma.

Authors:  Ewelina Lachowicz; Wojciech Lubiński; Wojciech Gosławski; Elżbieta Andrysiak-Mamos; Agnieszka Kaźmierczyk-Puchalska; Anhelli Syrenicz
Journal:  Doc Ophthalmol       Date:  2021-03-20       Impact factor: 2.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.